Sign inJoin waitlistJoin the waitlist

Neda Nikbakht

Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine · Emory University School of Medicine

Credentials: · · · · ·

History

Emory University School of Medicine
Present
Emory University School of Medicine
Present

Dermatology
Thomas Jefferson University Hospital
2014–2017
Internal Medicine
Thomas Jefferson University Hospital
2013–2014
Sidney Kimmel Medical College at Thomas Jefferson University
2009–2013

Research

A model for anteroposterior patterning of the vertebrate limb based on sequential long- and short-range Shh signalling and Bmp signalling
Development · 2000 · 163 citations
In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms
Cancer Discovery · 2018 · 69 citations
Keloid Disorder: Genetic Basis, Gene Expression Profiles, and Immunological Modulation of the Fibrotic Processes in the Skin
Review · Cold Spring Harbor Perspectives in Biology · 2023 · 45 citations

Pierluigi Porcu
27 papers
LB
Lauren Banner
17 papers · 7 as a resident
LG
Laura Gleason
16 papers · 2 as a resident
Onder Alpdogan
15 papers
SB
Safiyyah Bhatti
15 papers
JM
Jenna Mandel
13 papers · 3 as a resident
DJ
Daniel Joffe
12 papers · 3 as a resident
JL
Jason Lee
11 papers
DS
Doaa Shalabi
10 papers · 1 as a resident
Megan O’Donnell-Cappelli
10 papers · 6 as a resident
Henry Yang
9 papers · 6 as a resident
SK
Saritha Kartan
8 papers

Grants

The Malignant Microenvironment in Early Cutaneous T-Cell Lymphoma
National Cancer Institute · R03
Contact PI · $156K · Thomas Jefferson University
2021–2024
Role of BAFF in Regulation of B Cell Peripheral Tolerance
National Heart, Lung, and Blood Institute · F30
Contact PI · $88.5K · Thomas Jefferson University
2011–2015

Clinical trials

Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC
Principal investigator · Completed · Early phase 1
Thomas Jefferson University
2021–2025
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Site PI · Recruiting
City of Hope Medical Center
2024–2026